Replies to post #696377 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

For the record I have been saying they are dogsh!t for ages so no sudden change from me. Their historical cap raising tendencies have had less fiduciary concern to shareholders because they had their trueup strategy in mind. Disappointed that since the lawsuit they haven't made an effort to raise a large chunk at once knowing they weren't going to deliver anything for months/years.

Right there with you. I've been complaining about the 'death by a thousand cuts' dilutive financing for years. It's just odd to me that this relatively minor deal, which is really just 'business as usual', seems like it's the tipping point for a lot of people.

Management has this weird mindset that it doesn't matter if the share price gets over a buck in the short term because it's just going to be 'manipulated' back down to $0.50 by nefarious forces, so why bother doing anything to support the share price pre-approval at all? When in reality, it matters hugely. Generate positive PR and use those runs to generate cash and limit dilution. Even if you know it's gonna get knocked back down. Look at GME - they know how to capitalize on the pump.

Can't tell you how many times I've had this argument with DI.